News | December 05, 2011

Obesity Predicts Higher Quality Of Life Following AF Catheter Ablation

December 5, 2011 – New study shows significant increase in quality of life (QoL) among overweight patients following ablation of atrial fibrillation (AF), compared to patients with a lower body mass index (BMI) where no substantial improvement was observed.  The study, published in the December edition of HeartRhythm, the official journal of the Heart Rhythm Society, reveals an association between BMI and a change in QoL between the pre- and postablation periods in a large AF patient cohort.  The study also verifies comparable procedural success rates of ablation in both overweight and lean patients. 

This study, co-led by Sanghamitra Mohanty, M.D., and Andrea Natale, M.D., at St. David’s Medical Center (SDMC) in Austin, Texas, is the first to use four different assessment tools* to measure QoL in AF patients undergoing catheter ablation, and examined the association between BMI and improvement in QoL scores following ablation in 660 patients.  Patients were categorized into two groups: lean or normal with a normal-BMI (BMI < 25) and overweight or obese with a high-BMI (BMI ? 25), 79 percent of patients had a high-BMI.  Patients were asked to participate in self-administered QoL surveys before and 12 months after the catheter ablation procedure.

While high-BMI patients started with a lower baseline QoL score compared to normal-BMI patients, 12-month postablation QoL scores among the high-BMI group improved significantly in all measures except physical functioning and bodily pain.  Specifically, improvement was observed in role limitations due to physical health (27 percent), role limitations due to emotional problem (22.6 percent) and vitality (21.9 percent).  The high-BMI group also reported reductions in anxiety and depression levels after ablation procedures.  Overall, long-term ablation success was the same in both the normal-BMI group (69 percent) and high-BMI group (63 percent).

“Despite reporting improvement in QoL and comparable procedure-success in obese and overweight patients, this study does not attempt to trivialize the importance of interventions to promote weight loss and adaptation of healthy life style,” said co-lead author Mohanty at SDMC, Austin, Texas. “Obesity still remains a potential risk-factor for AF and many other cardio-vascular diseases and active measures should be taken to reverse this potentially modifiable risk factor.”

*Quality of Life Assessment tools used in the study include, Medical Outcomes Study Short Form-36 (SF-36), Beck Depression Inventory (BDI), Hospital Anxiety and Depression (HAD) scale, and State-Trait Anxiety Inventory (STAI).

For more information: www.hrsonline.org/publications/

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now